Cytek Biosciences
Yahoo Finance • 16 days ago
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global... Full story
Yahoo Finance • 22 days ago
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that its Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Award... Full story
Yahoo Finance • 22 days ago
Cytek Biosciences to Participate in Upcoming Investor Conferences
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. UBS Global He... Full story
Yahoo Finance • 23 days ago
Cytek reaffirms $196M–$205M 2025 revenue outlook as recurring businesses accelerate
Earnings Call Insights: Cytek Biosciences (CTKB) Q3 2025 MANAGEMENT VIEW * CEO Wenbin Jiang highlighted that "total revenue reached $52.3 million, representing a year-over-year increase of 2% compared to the same period in 2024." Jiang... Full story
Yahoo Finance • 23 days ago
Cytek (CTKB) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool. Date Wednesday, November 5, 2025 at 4:30 p.m. ET Call participants Chief Executive Officer — Wenbin Jiang Chief Financial Officer — William D. McCombe Investor Relations — Paul Goodson Need a quote fro... Full story
Yahoo Finance • 30 days ago
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. (Nasdaq: CTKB) is taking steps to ens... Full story
Yahoo Finance • last month
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
FREMONT, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter 2025 after market close on Wednesday, Nove... Full story
Yahoo Finance • last month
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
FREMONT, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- In a move that strengthens its European operations and enhances service for its customers, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the reloc... Full story
Yahoo Finance • 3 months ago
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) will showcase its advan... Full story
Yahoo Finance • 3 months ago
3 Promising Penny Stocks With Market Caps Under $600M
As the U.S. stock market reaches new heights, with major indices like the S&P 500 and Dow Jones Industrial Average closing at record levels, investors are keenly eyeing opportunities that may not be immediately obvious. Penny stocks, a ter... Full story
Yahoo Finance • 4 months ago
Piper Sandler sees opportunity in dislocated Life Science stocks
Investing.com - Piper Sandler has identified potential buying opportunities in dislocated Life Science Tools & Labs stocks, particularly highlighting Neogenomics (NASDAQ:NEO), Myriad Genetics (NASDAQ:MYGN), and Cytek Biosciences (NASDA... Full story
Yahoo Finance • 4 months ago
Cytek Biosciences, Inc. (CTKB): A Bull Case Theory
This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return potential, read our free article: 10 Promising SmallCap Stocks Under $1 Billion Market Cap. We came across a bullish the... Full story
Yahoo Finance • 4 months ago
Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025
FREMONT, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the second quarter 2025 after market close on Wednesday, Aug... Full story
Yahoo Finance • 5 months ago
Cytek Biosciences shareholders elect directors and approve auditor at annual meeting
Cytek Biosciences , Inc. (NASDAQ:CTKB), a life sciences company currently trading below its InvestingPro Fair Value despite maintaining strong liquidity metrics, held its 2025 annual meeting of stockholders on Wednesday, June 18. The compa... Full story
Yahoo Finance • 6 months ago
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of the Cytek Aurora™ Evo system, a new... Full story
Yahoo Finance • 6 months ago
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th Annual Global Healt... Full story
Yahoo Finance • 8 months ago
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
FREMONT, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Today, Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that it has added transformative capabilities to its iconic Cytek® Guava® Muse® cell analyzer, creating a next-generation instrum... Full story
Yahoo Finance • 9 months ago
Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
FREMONT, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2024 after market close on... Full story
Yahoo Finance • 2 years ago
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
FREMONT, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Piper Sandler 35th Annual Healthcare... Full story
Yahoo Finance • 2 years ago
Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
FREMONT, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that its Cytek® Aurora™ CS system has been selected as the “Cell Sorting Product of the... Full story
